Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Most skin changes during pregnancy go away after giving birth.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

AMH is a good marker for diagnosing PCOS, but global standards are needed.